[1]
Kaya, S.Y. et al. 2025. Real-Life Experience of Hepatitis C Treatment with Direct-Acting Antivirals in Genotypes 2 and 3. Turkish Journal of Gastroenterology. (Sep. 2025). DOI:https://doi.org/10.5152/tjg.2025.24751.